A Study of Onapristone ER in Gynecologic Cancers That Respond to Progesterone

Conditions:   Granulosa Cell Ovarian Cancer;   Low Grade Serous Ovarian/ Primary Peritoneal Cancer;   Endometrioid Endometrial Cancer Intervention:   Drug: Onapristone ER Sponsors:   Memorial Sloan Kettering Cancer Center;   Context Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials